MER vs. CVSG, XPS, DTY, AA, PVG, XAF, DWL, CRN, PETS, and DOCS
Should you be buying Mears Group stock or one of its competitors? The main competitors of Mears Group include CVS Group (CVSG), XPS Pensions Group (XPS), Dignity (DTY), AA (AA), Premier Veterinary Group plc (PVG.L) (PVG), Xafinity (XAF), Dowlais Group (DWL), Cairn Homes (CRN), Pets at Home Group (PETS), and Dr. Martens (DOCS). These companies are all part of the "consumer cyclical" sector.
Mears Group vs. Its Competitors
CVS Group (LON:CVSG) and Mears Group (LON:MER) are both small-cap consumer cyclical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.
CVS Group has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500. Comparatively, Mears Group has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500.
Mears Group has a net margin of 3.67% compared to CVS Group's net margin of 3.20%. Mears Group's return on equity of 21.83% beat CVS Group's return on equity.
48.5% of CVS Group shares are held by institutional investors. Comparatively, 64.6% of Mears Group shares are held by institutional investors. 1.4% of CVS Group shares are held by insiders. Comparatively, 1.6% of Mears Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
In the previous week, Mears Group had 1 more articles in the media than CVS Group. MarketBeat recorded 1 mentions for Mears Group and 0 mentions for CVS Group. Mears Group's average media sentiment score of 0.30 beat CVS Group's score of 0.00 indicating that Mears Group is being referred to more favorably in the news media.
Mears Group has higher revenue and earnings than CVS Group. Mears Group is trading at a lower price-to-earnings ratio than CVS Group, indicating that it is currently the more affordable of the two stocks.
CVS Group currently has a consensus price target of GBX 1,750, suggesting a potential upside of 41.59%. Mears Group has a consensus price target of GBX 475, suggesting a potential upside of 52.24%. Given Mears Group's higher probable upside, analysts plainly believe Mears Group is more favorable than CVS Group.
CVS Group pays an annual dividend of GBX 0.08 per share and has a dividend yield of 0.0%. Mears Group pays an annual dividend of GBX 0.16 per share and has a dividend yield of 0.1%. CVS Group pays out 210.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Mears Group pays out 30.0% of its earnings in the form of a dividend. Mears Group is clearly the better dividend stock, given its higher yield and lower payout ratio.
Summary
Mears Group beats CVS Group on 14 of the 16 factors compared between the two stocks.
Get Mears Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for MER and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding MER and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Mears Group Competitors List
Related Companies and Tools
This page (LON:MER) was last updated on 9/23/2025 by MarketBeat.com Staff
